This episode features Yashar Seyed Vahedein, CEO and Co-founder of Coredio, a company tackling the significant problem of heart failure management. Yashar outlines the immense global and US prevalence of heart failure, the high rates of readmission due to inadequate post-discharge monitoring, and the substantial financial burden this places on hospitals and payers. He highlights the limitations of current standard care (blood pressure cuffs and scales) in providing timely and accurate cardiac insights, contrasting them with the invasiveness and cost of solutions like catheterization and implantable devices.

Coredio's innovative solution is a software platform that leverages existing wearable devices (like smartwatches and blood pressure cuffs) and patented AI and physics-based technology to extract key cardiac metrics comparable to those obtained through invasive procedures. This non-invasive approach aims to improve guideline-directed medication therapy adherence, reduce hospital readmissions and length of stay, and ultimately enhance patient outcomes by providing clinicians with timely data and enabling proactive intervention – all without requiring new devices for patients or hospitals. Tune in to learn more about this exciting startup so you can be informed and inspired.

In this episode, hosts Kyle Kruse and Richard Meiklejohn, interview Joseph ‘Yossi’ Mossel, CEO and Co-founder of Ibex Medical Analytics, about the company's innovative use of AI in cancer diagnostics. Yossi discusses the critical problem of diagnostic errors in pathology, which can reach up to 10% in some labs, and the growing shortage of pathologists worldwide. Ibex's AI technology acts as a "digital assistant" to pathologists, pre-analyzing cases and highlighting areas of concern, thereby increasing accuracy and efficiency.

Yossi emphasizes that Ibex's AI is designed to augment, not replace, pathologists, allowing them to focus on complex cases while ensuring accuracy in routine diagnoses. The conversation touches on all the incredible data and partner foundations that been developed, which has led to significant deployments in Europe and the United States. Tune in to learn more about how Ibex is re-shaping pathology so you can be informed and inspired.

In this episode, we sit down with Dr. Nicholas Nikolov, Chief Medical Officer of Cellsound Aesthetics, to discuss a revolutionary approach to aesthetic treatments. Dr. Nikolov, a plastic surgeon, shares his journey from traditional invasive procedures to pioneering non-invasive solutions using non-focused ultrasound technology. Cellsound Aesthetics aims to rejuvenate tissue, improve blood flow, and contour the body without causing trauma or downtime. Dr. Nikolov details how the technology, originally developed for wound healing, has evolved to address various aesthetic concerns, offering patients a comfortable and effective alternative to traditional methods.

Dr. Nikolov explains the science behind Cellsound, highlighting its unique ability to penetrate deep tissue layers and stimulate cellular activity without causing injury. He emphasizes the importance of patient comfort and the positive impact of the technology on their overall well-being. The conversation also delves into the company's go-to-market strategy, clinical study results, and the comprehensive training and support provided to practitioners. Dr. Nikolov's passion for the technology and its potential to transform the aesthetic industry is evident, making this episode one sure to leave you informed and inspired.